| Pharmaceuticals Industry | Healthcare Sector | Mr. Adam Buchajski CEO | XDUS Exchange | FR0000120578 ISIN |
| Poland Country | 88 Employees | 5 May 2026 Last Dividend | - Last Split | - IPO Date |
Sanofi SA is a prominent French multinational pharmaceutical and healthcare company based in Paris, recognized for its dedication to the research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, the company has grown significantly through pivotal mergers, including those with Synthélabo in 1999 and Aventis in 2004, creating a global entity with a workforce exceeding 90,000 employees across 90 countries. Sanofi strategically focuses on seven major therapeutic areas: cardiovascular health, central nervous system disorders, diabetes care, internal medicine, oncology, thrombosis prevention, and vaccine development. Notably, it stands as the world's largest producer of vaccines through its subsidiary, Sanofi Pasteur, reinforcing its commitment to public health. The company maintains a strong emphasis on research and development, utilizing AI-driven methodologies to focus on immunology, neurology, diabetes innovation, and mRNA technologies, while managing a robust pipeline of 80 compounds in clinical development aimed at addressing unmet medical needs worldwide.
Sanofi’s portfolio includes leading prescription medications such as Dupixent, which is utilized for treating eczema and various autoimmune conditions, demonstrating significant advancements in dermatological and immunological therapies.
This medication is essential for thrombosis management, serving as an anticoagulant that prevents and treats blood clots, playing a crucial role in patient care for at-risk populations.
Used in cancer treatment, Taxotere is an important chemotherapy agent that assists in managing various cancer types, contributing to the broader oncology therapeutic landscape.
Sanofi provides specialized treatments for rare conditions, such as Gaucher's disease and hemophilia, reflecting its commitment to addressing the needs of patients with unique medical challenges.
The company also markets a range of over-the-counter products, including Allegra for allergy relief and IcyHot for pain management, making healthcare accessible beyond prescription needs.
Through Sanofi Pasteur, the company is the largest vaccine producer globally, developing and manufacturing vaccines that protect against various infectious diseases, thus playing a pivotal role in global vaccination efforts.